These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4906990)

  • 1. A comparison of rifampicin, ethambutol and PAS in short-term monotherapy. Preliminary results of the third cooperative study of the WATL.
    Schütz I
    Acta Tuberc Pneumol Belg; 1969; 60(3):437-41. PubMed ID: 4906990
    [No Abstract]   [Full Text] [Related]  

  • 2. Methods of clinical evaluation of rifampicin-activity.
    Trendelenburg F
    Acta Tuberc Pneumol Belg; 1969; 60(3):432-6. PubMed ID: 4906099
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of rifampicin, ethambutol or PAS in short-term monotherapy in pretreated cavitary pulmonary tuberculosis.
    Pneumonologie; 1975 Dec; 153(1):43-59. PubMed ID: 1105471
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
    Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
    [No Abstract]   [Full Text] [Related]  

  • 5. [Rifomycin in treatment of chronic tuberculosis with bacilli resistant to standard medications].
    Nitti V; Delli Veneri F; Marra A
    Acta Tuberc Pneumol Belg; 1969; 60(3):455-65. PubMed ID: 4906100
    [No Abstract]   [Full Text] [Related]  

  • 6. The impact of rifampicin on the treatment of tuberculosis.
    Bayliss CG
    Bull Int Union Tuberc; 1974 Aug; 49 suppl 1():140-3. PubMed ID: 4467983
    [No Abstract]   [Full Text] [Related]  

  • 7. Results of clinical studies with capreomycin, ethambutol and rifampicin in the Heckeshorn Hospital, Berlin.
    Radenbach KL
    Scand J Respir Dis Suppl; 1969; 69():43-53. PubMed ID: 4906373
    [No Abstract]   [Full Text] [Related]  

  • 8. [Reduction of fresh forms of pulmonary tuberculosis by the classical treatment and by combined antibiotics including rifampicin (comparative study of a personal survey)].
    Weill G; Lévy A; Guignon JP; Lecoq H; Friess JM; Maman P
    Rev Tuberc Pneumol (Paris); 1969 Dec; 33(8):1119-25. PubMed ID: 4916253
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of tuberculosis].
    Vale JR
    Tidsskr Nor Laegeforen; 1975 Dec; 95(34-36):1991-2. PubMed ID: 1209576
    [No Abstract]   [Full Text] [Related]  

  • 10. Hospital-based ambulatory treatment of tuberculosis with capreomycin, ethambutol, and-or rifampicin.
    Riska N
    Scand J Respir Dis Suppl; 1969; 69():75-9. PubMed ID: 4906378
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical evaluation of Rifampicin in pulmonary tuberculosis. 2. A controlled trial on the clinical effects of chemotherapy with Rifampicin-INH-PAS and SM-INH-PAS for treatment of original cases of pulmonary tuberculosis].
    Donomae I; Fujita S; Gomi J; Hibino S; Horai Z
    Kekkaku; 1970 Aug; 45(8):257-62. PubMed ID: 4918166
    [No Abstract]   [Full Text] [Related]  

  • 12. [Progress in the treatment of tuberculosis. Isoniazid plus rifomycin plus myambutol equals standard therapy].
    Freerksen E
    Dtsch Med Wochenschr; 1970 Jan; 95(3):139-41. PubMed ID: 5411222
    [No Abstract]   [Full Text] [Related]  

  • 13. [Rifampicin in the treatment of tuberculosis].
    Mattson K
    Duodecim; 1973; 89(11):807-17. PubMed ID: 4758893
    [No Abstract]   [Full Text] [Related]  

  • 14. [Symposium: chemotherapy including new antitubercular agents].
    Fukuhara T; Yoshida F; Sasaoka A; Mitsui M
    Kekkaku; 1971 Feb; 46(2):3-4. PubMed ID: 5549795
    [No Abstract]   [Full Text] [Related]  

  • 15. [Current views on drug treatment of tuberculosis].
    Repo K; Riska N
    Duodecim; 1970; 86(21):1268-78. PubMed ID: 5490929
    [No Abstract]   [Full Text] [Related]  

  • 16. [New drugs in antitubercular therapy].
    Favez G
    Helv Med Acta Suppl; 1969; 49():66-80. PubMed ID: 4912509
    [No Abstract]   [Full Text] [Related]  

  • 17. [Intermittent treatment of "intractable chronic tuberculosis" by combined rifampicin-ethambutol: preliminary results of a controlled survey made in Algeria].
    Larbaoui D; Chaulet P; Grosset J; Abderrahim K; Oussedik N; Coucke C; Benabdallah L
    Rev Tuberc Pneumol (Paris); 1970 Jun; 34(4):559-66. PubMed ID: 4928583
    [No Abstract]   [Full Text] [Related]  

  • 18. Report on the therapeutic results obtained with rifampicin.
    Böszörményi M
    Antibiot Chemother; 1970; 16():487-9. PubMed ID: 5523734
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of chronic tuberculosis with ethambutol and prothionamide associated with rifomycin of capreomycin].
    Grassi C
    Acta Tuberc Pneumol Belg; 1969; 60(3):450-4. PubMed ID: 4906991
    [No Abstract]   [Full Text] [Related]  

  • 20. [Changes in the bacteriologic findings in patients treated with rifomycin, alone or associated with other drugs].
    Delli Veneri F; Centrella G; Stefanelli R
    Arch Tisiol Mal Appar Respir; 1968 May; 23(5):387-98. PubMed ID: 4979475
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.